Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study

Trial Profile

Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study

Active, no longer recruiting
Phase of Trial: Phase 0

Latest Information Update: 02 Apr 2018

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 29 Mar 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Dec 2018.
    • 13 Dec 2017 Planned primary completion date changed from 1 Dec 2020 to 1 Jan 2018.
    • 02 Aug 2016 Results published in the Thorax
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top